[Prevention of pulmonary thromboembolism by percutaneous implantation of REPTELA vena cava-filter].
Experience in clinical application of the new antiembolic REPTELA cava-filter is generalized. The immediate (750 patients) and late-term results (400 patients) of implantation of the filter are discussed. Thromboembolism of the pulmonary artery was encountered in the postimplantation period in 1.2% of patients with 0.2% lethality. Technical faults of implantation were the causes of antiembolic inefficacy of the cava-filter.